2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine
| Product Name | 2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine |
|---|---|
| Alternate Names | Capecitabine Impurities, Impurities of Capecitabine |
| CAT No. | CS-T-52017 |
| CAS No. | 1262133-66-3 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 475.5 g/mol |
| Mol. For. | C20H30FN3O9 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Capecitabine |
| Purity | Not less than 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)OC3C(C(C(O3)C)O)O |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine is a prodrug used in the treatment of breast, colon, and gastric cancer. It is an oral chemotherapy agent that is converted to its active form, 5-fluorouracil (5-FU), by a series of enzymatic reactions in the body. The conversion process involves the removal of the 5’-deoxy group from the ribose sugar, followed by the sequential addition of three phosphate groups to the molecule. Once converted to 5-FU, the drug inhibits the synthesis of DNA and RNA, thereby preventing the growth and division of cancer cells.
The chemical structure of 2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine consists of a fluoropyrimidine nucleoside analog linked to a 5’-deoxyribose sugar moiety. The drug is administered orally and is rapidly absorbed from the gastrointestinal tract. The pharmacokinetics of the drug are complex and depend on several factors, including the patient’s age, body weight, and renal function.
Despite its efficacy in the treatment of cancer, 2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine can cause several adverse effects, including gastrointestinal toxicity, hand-foot syndrome, and myelosuppression. Patients receiving the drug require careful monitoring and management of side effects to ensure optimal treatment outcomes. Overall, 2’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine is a valuable treatment option for cancer patients and is an important component of many chemotherapy regimens.
Get an Instant Quote
Related Compounds
Capecitabine Impurity 5 | Capecitabine-2',3'-cyclic Carbonate | Capecitabine Isomers | Capecitabine USP Impurity I |